KRT20 Antikörper (AA 196-323)
Kurzübersicht für KRT20 Antikörper (AA 196-323) (ABIN7871734)
Target
Alle KRT20 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 196-323
-
Verwendungszweck
- Cytokeratin 20 Antibody / CK20 / KRT20
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant fragment of human KRT20 protein (within amino acids 196-323) was used as the immunogen for the Cytokeratin 20 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the Cytokeratin 20 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Cytokeratin 20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- KRT20 (Keratin 20 (KRT20))
-
Andere Bezeichnung
- Cytokeratin 20
-
Hintergrund
- This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.
-
UniProt
- P35900
Target
-